![From left to right, scientists Sadeem Qdaisat, Hector Méndez and Elias Sayour, co-creators of the experimental vaccine against glioblastoma, at the University of Florida.](https://imagenes.elpais.com/resizer/v2/YCJROR53RBFLTOWFXDINWFH5EU.jpg?auth=07710ccafa03598e52b358fbd4586b658115e0986bdf617ebb3eb9a338b07def&width=414&height=233&smart=true)
An experimental vaccine increases survival rates by up to 50% in four people with highly-aggressive brain cancer
Spanish biochemist Héctor Méndez and his colleagues from the University of Florida have achieved ‘promising’ results in their initial human trial